Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens
/in Dendritic Cells, International Publications, Prostate Cancer /von 2009-04-11 / Urol. Oncol. 2010 May-Jun;28(3):290-5Vaccination strategies in patients with renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International Publications /von 2009-04-10 / Cancer Immunol. Immunother. 2009 Jul;58(7):1169-74Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia
/in Cervical Cancer, Hyperthermia, International Publications /von 2009-04-08 / Eur. J. Cancer 2009 Jul;45(11):1969-78A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2009-04-01 / Pancreas 2009 Apr;38(3):e69-74Cross-infection of tumor cells by contact with T lymphocytes loaded with Newcastle disease virus
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2009-04-01 / Int. J. Oncol. 2009 Apr;34(4):951-62Expression of RIG-I, IRF3, IFN-beta and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2009-04-01 / Int. J. Oncol. 2009 Apr;34(4):971-82Cutting Edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells
/in International Publications, Newcastle Disease Virus /von 2009-04-01 / J. Immunol. 2009 Apr;182(7):3960-4Use of the concept of equivalent biologically effective dose (BED) to quantify the contribution of hyperthermia to local tumor control in radiohyperthermia cervical cancer trials, and comparison with radiochemotherapy results
/in Hyperthermia, International Publications /von 2009-04-01 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Apr;73(5):1538-44DCVax-Brain and DC vaccines in the treatment of GBM
/in Dendritic Cells, Glioblastoma, International Publications /von 2009-04-01 / Expert Opin Investig Drugs 2009 Apr;18(4):509-19
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de